portrazza - necitumumab solution
(Necitumumab)Eli Lilly And Company
Usage: Portrazza is an EGFR antagonist used with gemcitabine and cisplatin as first-line treatment for metastatic squamous non-small cell lung cancer. Not indicated for non-squamous NSCLC.